Meeting
2017 ASCO Annual Meeting
Response to pembrolizumab in patients with mismatch repair deficient (dMMR) colorectal cancer (CRC).
Authors
Alexis Diane Leal
Mayo Clinic, Rochester, MN
Alexis Diane Leal , Jonas Paludo , Heidi D. Finnes , Axel Grothey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3558)
DOI
10.1200/JCO.2017.35.15_suppl.3558
Abstract #
3558
Poster Bd #
181
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
PD-1 blockade in mismatch repair deficient non-colorectal gastrointestinal cancers.
First Author: Dung T. Le
Poster
2022 ASCO Annual Meeting
The differential response to immune checkpoint inhibitors in colorectal and endometrial cancer patients according to different mismatch repair alterations.
First Author: Moh'd M. Khushman
Poster
2020 Gastrointestinal Cancers Symposium
Predicting CD8+ T-cell infiltration in colorectal cancer using versican proteolysis across molecular profiles.
First Author: Katherine Anne Johnson
Poster
2017 Gastrointestinal Cancers Symposium
Tumor mutational burden of microsatellite stable metastatic colorectal tumors by patient factors and KRAS, BRAF, and PIK3CA mutation status.
First Author: Jun Gong